scispace - formally typeset
Open AccessJournal ArticleDOI

Toward a more accurate estimate of the prevalence of hepatitis C in the United States

Reads0
Chats0
TLDR
The number of US residents who have been infected with hepatitis C is unknown but is probably at least 4.6 million, although additional sources of potential underestimation suggest that the true prevalence could well be higher.
About
This article is published in Hepatology.The article was published on 2015-11-01 and is currently open access. It has received 371 citations till now.

read more

Citations
More filters
Journal ArticleDOI

Cancer statistics, 2019.

TL;DR: The overall cancer death rate dropped continuously from 1991 to 2016 by a total of 27%, translating into approximately 2,629,200 fewer cancer deaths than would have been expected if death rates had remained at their peak.
Journal ArticleDOI

Cancer statistics, 2020.

TL;DR: Slow momentum for some cancers amenable to early detection is juxtaposed with notable gains for other common cancers, and it is notable that long‐term rapid increases in liver cancer mortality have attenuated in women and stabilized in men.
Journal ArticleDOI

Cancer Statistics, 2021.

TL;DR: In the United States, the cancer death rate has dropped continuously from its peak in 1991 through 2018, for a total decline of 31%, because of reductions in smoking and improvements in early detection and treatment as mentioned in this paper.
References
More filters
Journal ArticleDOI

The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994

TL;DR: The strongest factors independently associated with HCV infection were illegal drug use and high-risk sexual behavior, and poverty, having had 12 or fewer years of education, and having been divorced or separated were independently associated.
Journal ArticleDOI

Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence.

TL;DR: The high prevalence of global HCV infection necessitates renewed efforts in primary prevention, including vaccine development, as well as new approaches to secondary and tertiary prevention to reduce the burden of chronic liver disease and to improve survival for those who already have evidence of liver disease.
Journal ArticleDOI

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.

TL;DR: To determine the characteristics of HCV-infected persons in the general United States population today and to monitor trends in prevalence, data on HCV infection from the most recent NHANES was analyzed.
Related Papers (5)